# A Low-Interventional Study of an Electronic Sickle Cell Disease Patient Reported Outcomes in Sickle Cell Participants

> **NCT06503458** · — · TERMINATED · sponsor: **Sanguine Biosciences** · enrollment: 52 (actual)

## Conditions studied

- Sickle Cell Disease
- Sickle Cell Anemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06503458
- **Lead sponsor:** Sanguine Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2022-01-19
- **Primary completion:** 2023-12-23
- **Final completion:** 2024-04-10
- **Target enrollment:** 52 (ACTUAL)
- **Why stopped:** Low enrollment, cohorts were not able to be filled
- **Last updated:** 2024-07-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06503458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06503458, "A Low-Interventional Study of an Electronic Sickle Cell Disease Patient Reported Outcomes in Sickle Cell Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06503458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*